Analystreport

Histogenics Corp. (NASDAQ: HSGX) was given a new $4.00 price target on by analysts at HC Wainwright. They now have a "buy" rating on the stock.

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com